Modified cAMP derivatives: Powerful tools in heart research

Current Medicinal Chemistry

Volumn 18, Issue 24, 2011, Pages 3729-3736

  Szentandrassy N ^a   Harmati, G ^a   Farkas, V ^a   Horvath B ^a   Hegyi, B ^a   Magyar, J ^a   Szenasi G ^b   Marton I ^a   Nanasi P P ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b EGIS PHARMACEUTICALS LTD   (Hungary)

Author keywords

Adrenergic stimulation; CAMP analogues; Dog myocytes; EPAC; Intracellular compartmentalization; Phosphodiesterase; Protein kinase A; Rapid delayed rectifier K + current

Indexed keywords

8 BROMO CYCLIC AMP; ADENINE; ANTIPORTER; BETA ADRENERGIC RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DERIVATIVE; EPAC PROTEIN; HALOGEN; NITROGEN; POTASSIUM; POTASSIUM CHANNEL HERG; SULFUR; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADRENERGIC STIMULATION; AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CELL COMPARTMENTALIZATION; CELL DENSITY; CLINICAL RESEARCH; ENZYME ACTIVATION; ENZYME BINDING; ENZYME INHIBITION; HEART; HEART MUSCLE CELL; HEART VENTRICLE; HUMAN; INHIBITION KINETICS; NONHUMAN; NUCLEIC ACID STRUCTURE; POTASSIUM CURRENT; PROTEIN PHOSPHORYLATION;

ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC NUCLEOTIDE-GATED CATION CHANNELS; DOGS; FORSKOLIN; GUANINE NUCLEOTIDE EXCHANGE FACTORS; ISOPROTERENOL; MEMBRANE POTENTIALS; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SIGNAL TRANSDUCTION;

EID: 80051994544     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711796642445     Document Type: Article

References (62)

1. Sunahara, R.K.; Dessauer, C.W.; Gilman, A.G. Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol., 1996, 36, 461-480. (Pubitemid 26168706)
2. Fimia, G.M.; Sassone-Corsi, P. Cyclic AMP signalling. J. Cell Sci., 2001, 114, 1971-1972. (Pubitemid 32586622)
3. Defer, N.; Best-Belpomme, M.; Hanoune, J. Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. Am. J. Physiol., 2000, 279, F400-F416.
4. Hanoune, J.; Defer, N. Regulation and role of adenylyl cyclase isoforms. Annu. Rev. Pharmacol. Toxicol., 2001, 41, 145-174. (Pubitemid 32385886)
5. Lugnier, C. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol. Ther., 2006, 109, 366-398. (Pubitemid 43132818)
6. Cheng, J.; Grande, J.P. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease. Exp. Biol. Med., 2007, 232, 38-51. (Pubitemid 46089939)
7. Shabb, J.B. Physiological substrates of cAMP-dependent protein kinase. Chem. Rev., 2001, 101, 2381-2411. (Pubitemid 35373025)
8. Øgreid, D.; Døskeland, S.O.; Miller, J.P. Evidence that cyclic nucleotides activating rabbit muscle protein kinase I interact with both types of cAMP binding sites associated with the enzyme. J. Biol. Chem., 1983, 258, 1041-1049. (Pubitemid 13139349)
9. Øgreid, D.; Døskeland, S.O. Activation of protein kinase isoenzymes under near physiological conditions. Evidence that both types (A and B) of cAMP binding sites are involved in the activation of protein kinase by cAMP and 8-N3-cAMP. FEBS Lett., 1982, 150, 161-166. (Pubitemid 13149320)
10. Robinson-Steiner, A.M.; Corbin, J.D. Probable involvement of both in-trachain cAMP binding sites in activation of protein kinase. J. Biol. Chem., 1983, 258, 1032-1040.
11. Hove-Madsen, L.; Méry, P.F.; Jurevicius, J.; Skeberdis, A.V.; Fischmeister, R. Regulation of myocardial calcium channels by cyclic AMP metabolism. Basic Res. Cardiol., 1996, 91, Suppl 2, 1-8. (Pubitemid 26397769)
12. Walsh, K.B.; Kass, R.S. Regulation of a heart potassium channel by protein kinase A and C. Science, 1988, 242, 67-69.
13. + currents in canine ventricular cardiomyocytes. B r. J. Pharmacol., 2011, 162, 890-896.
14. Bahinski, A.; Nairn, A.C.; Greengard, P.; Gadsby, D.C. Chloride conductance regulated by cyclic AMP-dependent protein kinase in cardiac myocytes. Nature, 1989, 340, 718-721. (Pubitemid 19214391)
15. Smith, F.D.; Langeberg, L.K.; Scott, J.D. The where's and when's of kinase anchoring. Trends Biochem. Sci., 2006, 31, 316-323. (Pubitemid 43903241)
16. McConnachie, G.; Langeberg, L.K.; Scott, J.D. AKAP signaling complexes: getting to the heart of the matter. Trends Mol. Med., 2006, 12, 317-323. (Pubitemid 44110003)
17. De Rooij, J.; Zwartkruis, F.J.; Verheijen, M.H.; Cool, R.H.; Nijman, S.M.; Wittinghofer, A.; Bos, J.L. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature, 1998, 396, 474-477. (Pubitemid 28553318)
18. Bos, J.L. Epac proteins: multi-purpose cAMP targets. Trends Biochem. Sci., 2006, 31, 680-686. (Pubitemid 44791945)
19. Holz, G.G.; Kang, G.; Harbeck, M.; Roe, M.W.; Chepurny, O.G. Cell physiology of cAMP sensor Epac. J. Physiol. (London), 2006, 577, 5-15. (Pubitemid 44698236)
20. Métrich, M.; Berthouze, M.; Morel, E.; Crozatier, B.; Gomez, A.M.; Lezoualc'h, F. Role of the cAMP-binding protein Epac in cardiovascular physiology and pathophysiology. Pflügers Arch., 2010, 459, 535-546.
21. Helms, M.N.; Chen, X.J.; Ramosevac, S.; Eaton, D.C.; Jain, L. Dopamine regulation of amiloride-sensitive sodium channels in lung cells. Am. J. Physiol., 2006, 290, L710-L722. (Pubitemid 43725076)
22. Kang, G.; Chepurny, O.G.; Malester, B.; Rindler, M.J.; Rehmann, H.; Bos, J.L.; Schwede, F.; Koetzee, W.A.; Holz, G.G. cAMP sensor EPAC as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells. J. Physiol. (London), 2006, 573, 595-609. (Pubitemid 43842505)
23. - channels in rat hepatocytes. J. Physiol. (London), 2006, 573, 611-625. (Pubitemid 43842506)
24. + channels in cerebellar neurons. Proc. Natl. Acad. Sci. USA, 2007, 104, 2519-2524. (Pubitemid 46391428)
25. Baruscotti, M.; Bucchi, A.; DiFrancesco, D. Physiology and pharmacology of the cardiac pacemaker ("funny") current. Pharmacol. Ther., 2005, 107, 59-79. (Pubitemid 40800408)
26. DiFrancesco, D. The role of the funny current in pacemaker activity. Circ. Res., 2010, 106, 434-346.
27. DiFrancesco, D.; Tortora, P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature, 1991, 351, 145-147. (Pubitemid 21896552)
28. Jastorff, B.; Hoppe, J.; Moff, M. A model for chemical interactions of adenosine 3′:5′-monophosphate with the R subunit of protein kinase type I. Refinement of the cyclic phosphate binding moiety of protein kinase type I. Eur. J. Biochem., 1979, 101, 555-561.
29. Van Haastert, P.J.; Van Driel, R.; Jastorff, B.; Baraniak, J.; Stec, W.J.; De Wit, R.J. Competitive cAMP antagonists for cAMP-receptor proteins. J. Biol. Chem., 1984, 259, 10020-10024. (Pubitemid 14067669)
30. De Wit, R.J.W.; Hekstra, D.; Jastorff, B.; Stec, W.J.; Baraniak, J.; Van Driel, R.; Van Haastert, P.J.M. Inhibitory action of certain cyclophosphate derivatives of cAMP on cAMP-dependent protein kinases. Eur. J. Biochem., 1984, 142, 255-260. (Pubitemid 14093616)
31. Botelho, L.H.; Rothermel, J.D.; Coombs, R.V.; Jastorff, B. cAMP analog antagonists of cAMP action. Methods Enzymol., 1988, 159, 159-172.
32. De Wit, R.J.; Hoppe, J.; Stec, W.J.; Baraniak, J.; Jastorff, B. Interaction of cAMP derivatives with the 'stable' cAMP-binding site in the cAMP-dependent protein kinase type I. Eur. J. Biochem., 1982, 122, 95-99. (Pubitemid 12142823)
33. O'Brian, C.A.; Roczniak, S.O.; Bramson, H.N.; Baraniak, J.; Stec, W.J.; Kaiser, E.T. A kinetic study of interactions of (Rp)- and (Sp)-adenosine cyclic 3',5'-phosphorothioates with type II bovine cardiac muscle adenosine cyclic 3',5'-phosphate dependent protein kinase. Biochemistry, 1982, 21, 4371-4376.
34. Rehmann, H.; Schwede, F.; Døskeland, S.O.; Wittinghofer, A.; Bos, J.L. Ligand-mediated activation of the cAMP-responsive guanine nucleotide exchange factor Epac. J. Biol. Chem., 2003, 278, 38548-38556. (Pubitemid 37221750)
35. Bertinetti, D.; Schweinsberg, S.; Hanke, S.E.; Schwede, F.; Bertinetti, O.; Drewianka, S.; Genieser, H.G.; Herberg, F.W. Chemical tools selectively target components of the PKA system. BMC Chem. Biol., 2009, 9, 3.
36. Gjertsen, B.T.; Mellgren, G.; Otten, A.; Maronde, E.; Genieser, H.G.; Jastorff, B.; Vintermyr, O.K.; McKnight, G.S.; Døskeland, S.O. Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action. J. Biol. Chem., 1995, 270, 20599-20607.
37. Schwede, F.; Christensen, A.; Liauw, S.; Hippe, T.; Kopperud, R.; Jastorff, B.; Døskeland, S.O. 8-substituted cAMP analogues reveal marked differences in adaptability, hydrogen bonding, and charge accommodation between homologous binding sites (AI/AII and BI/BII) in cAMP kinase I and II. Biochemistry, 2000, 39, 8803-8812. (Pubitemid 30602789)
38. Meyer, RB; Miller, J.P. Analogs of cyclic AMP and cyclic GMP: general methods of synthesis and the relationship of structure to enzyme activity. Life Sci., 1974, 14, 1019-1040.
39. Holz, G.G.; Chempurny, O.G.; Schwede, F. Epac-selective cAMP analogues: new tools with which to evaluate the signal transduction properties of cAMPregulated guanine nucleotide exchange factors. Cell Signal., 2008, 20, 10-20. (Pubitemid 350138365)
40. Bartsch, M.; Zorn-Kruppa, M.; Kühl, N.; Genieser, H.G.; Schwede, F.; Jastorff, B. Bioactivatable, membrane-permeant analogs of cyclic nucleotides as biological tools for growth control of C6 glioma cells. Biol. Chem., 2003, 384, 1321-1326. (Pubitemid 37168701)
41. Christensen, A.E.; Selheim, F.; de Rooij, J.; Dremier, S.; Schwede, F.; Dao, K.K.; Martinez, A.; Maenhaut, C.; Bos, J.L.; Genieser, H.G.; Døskeland, S.O. cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. Biol. Chem., 2003, 278, 35394-33402.
42. Enserink, J.M.; Christensen, A.E.; de Rooij, J.; van Triest, M.; Schwede, F.; Genieser, H.G.; Døskeland, S.O.; Blank, J.L.; Bos, J.L. A novel Epacspecific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat. Cell Biol., 2002, 4, 901-906. (Pubitemid 35331366)
43. Su, Y.; Dostmann, W.R.; Herberg, F.W.; Durick, K.; Xuong, N.H.; Ten Eyck, L.; Taylor, S.S.; Varughese, K.I. Regulatory subunit of protein kinase A: structure of deletion mutant with cAMP binding domains. Science, 1995, 269, 807-813.
44. Kr, and the underlying hERG ion channel. Basic Res. Cardiol., 2004, 99, 279-287. (Pubitemid 38931232)
45. Thomas, D.; Zhang, W.; Karle, C.A.; Kathöfer, S.; Schöls, W.; Kübler, W.; Kiehn, J. Delation of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A. J. Biol. Chem., 1999, 274, 27457-27462.
46. Thomas, D.; Zhang, W.; Wu, K.; Wimmer, A.B.; Gut, B.; Wendt-Nordal, G.; Kathöfer, S.; Kreye, V.A.; Katus, H.A.; Schoels, W.; Kiehn, J.; Karle, C.A. Regulation of HERG potassium channel activation by protein kinase C independent of direct phosphorylation of the channel protein. Cardiovasc. Res., 2003, 59, 14-26. (Pubitemid 36776369)
47. Wei, Z.; Thomas, D.; Karle, C.A.; Kathöfer, S.; Schenkel, J.; Kreye, V.A.; Ficker, E.; Wible, B.A.; Kiehn, J. Proein kinase A-mediated phosphorylation of HERG potassium channels in a human cell line. Chin. Med. J., 2002, 115, 668-676. (Pubitemid 34594278)
48. 1-adrenoreceptor activation, via cAMP/protein kinase A-dependent pathways. Cardiovasc. Res., 2002, 53, 355-362. (Pubitemid 34117686)
49. Kr, through a reduction in C-type inactivation in guinea-pig ventricular myocytes. J. Physiol. (London), 2000, 522, 391-402. (Pubitemid 30088552)
50. Szentadrássy, N.; Bányász, T.; Bíró, T.; Szabó, G.; Tóth, B.; Magyar, J.; Lázár, J.; Varró, A.; Kovács, L.; Nánási, P. P. Apico-basal inhomogeneity in distribution of ion channels in canine and human ventricular myocardium. Cardiovasc. Res., 2005, 65, 851-860. (Pubitemid 40249729)
51. Szabó, G.; Szentandrássy, N.; Bíró, T.; Tóth, I.B.; Czifra, G.; Magyar, J.; Bányász, T.; Varró, A.; Kovács, L.; Nánási, P. P. Asymmetrical distribution of ion channels in canine and human left ventricular wall: epicardium versus midmyocardium. Pflügers Arch., 2005, 450, 307-316. (Pubitemid 41204177)
52. Zhang, G.; Liu, Y.; Ruoho, A.E.; Hurley, J.H. Structure of the adenylyl cyclase catalytic core of special interest. Nature, 1997, 386, 247-253. (Pubitemid 27142504)
53. 2+ channels by β-adrenergic agonists. Proc. Natl. Acad. Sci. USA, 1996, 93, 295-299.
54. Wong, W.; Scott, J.D. AKAP signalling complexes: focal points in space and time. Nat. Rev. Mol. Cell. Biol., 2004, 5, 959-970. (Pubitemid 39611533)
55. Dodge-Kafka, K.L.; Langeberg, L.; Scott J.D. Compartmentation of cyclic nucleotide signaling in the heart: the role of A-kinase anchoring proteins. Circ. Res., 2006, 98, 993-1001.
56. 2+ signals. Curr. Opin. Cell. Biol., 2002, 14, 160-166. (Pubitemid 34219504)
57. Zaccolo, M.; Pozzan, T. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science, 2002, 295, 1711-1715. (Pubitemid 34202906)
58. Fichmeister, R.; Castro, L.R.V.; Abi-Gerges, A.; Rochais, F.; Jurevicius, J.; Leroy J.; Vandecasteele G. Compartmentation of cyclic nucleotide signaling in the heart. The role of cyclic nucleotide phosphodiesterases. Circ. Res., 2006, 99, 816-828. (Pubitemid 44556380)
59. Bender, A.T.; Beavo, JA. Cyclic nucleotide phosphodiesterases: from molecular regulation to clinical use. Pharmacol. Rev., 2006, 58, 488-520. (Pubitemid 44394910)
60. Rich, T.C.; Fagan, K.A.; Tse, T.E.; Schaack, J.; Cooper, D.M.; Karpen, J.W. A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell. Proc. Natl. Acad. Sci. USA, 2001, 98, 13049-13054. (Pubitemid 33051315)
61. Steinberg, S.F.; Brunton, L.L. Compartmentation of G protein-coupled signaling pathways in cardiac myocytes. Annu. Rev. Pharmacol. Toxicol., 2001, 41, 751-773. (Pubitemid 32385905)
62. Cooper, D.M.F.; Crossthwaite, A.J. Higher-order organization and regulation of adenylyl cyclases. Trends Pharmacol. Sci., 2006, 27, 426-431. (Pubitemid 44069584)